Page Nct des essais cliniques
Clinical Trial Results:
A 22-week randomized, multicenter, parallel-group, double-blind study to compare a pimecrolimus 1 % (Elidel) twice daily (b.i.d.) maintenance dosing regimen to a once daily (o.d.) maintenance dosing regimen in the management of atopic dermatitis in pediatric subjects.
| Summary | |
EudraCT number | 2004-000940-26 |
Trial protocol | FI AT GB |
Global completion date | 05 Sep 2005 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 19 May 2018 |
First version publication date | 19 May 2018 |
Other versions | |
Summary report(s) | CASM981C2314 NVS CTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.